| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7280826 | Brain, Behavior, and Immunity | 2015 | 9 Pages |
Abstract
The recent availability of selective β5i subunit inhibitors opens up novel therapeutic opportunities for seizure inhibition in drug-resistant epilepsies.
Keywords
LPSHMGB1TLRTLE4-APMCAaCSF4-aminopyridine7-amino-4-methylcoumarinAChAcetylcholineNeuroinflammationImmunoproteasomestatus epilepticusToll-like receptorCNSseizure-like eventubiquitin–proteasome systemcentral nervous systemtemporal lobe epilepsySLElipopolysaccharideartificial cerebrospinal fluidProteasome inhibitorsPilocarpinehigh mobility group box-1UPS
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Michele Mishto, Muhammad L. Raza, Dario de Biase, Teresa Ravizza, Francesco Vasuri, Morena Martucci, Christin Keller, Elena Bellavista, Tonia J. Buchholz, Peter M. Kloetzel, Annalisa Pession, Annamaria Vezzani, Uwe Heinemann,